Physician preferences for chemotherapy in the treatment of non-small cell lung cancer in China: evidence from multicentre discrete choice experiments

OBJECTIVE: To evaluate physician risk-benefit preferences and trade-offs when making chemotherapy decisions for patients with non-small cell lung cancer (NSCLC). DESIGN: A discrete choice experiment (DCE). SETTINGS: Tertiary hospitals in Beijing, Shanghai, Guangzhou and Chengdu of China. PARTICIPANT...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Hui, Wang, Huishan, Shi, Lizheng, Wang, Meifeng, Li, Junling, Shi, Jufang, Ni, Ming, Hu, Xianzhi, Chen, Yingyao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045216/
https://www.ncbi.nlm.nih.gov/pubmed/32051302
http://dx.doi.org/10.1136/bmjopen-2019-032336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045216/
https://www.ncbi.nlm.nih.gov/pubmed/32051302
http://dx.doi.org/10.1136/bmjopen-2019-032336

Ejemplares similares